NCT05199428View on ClinicalTrials.gov

Optina Eye to Heart Connection

CompletedOBSERVATIONAL
Enrollment

308

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

March 22, 2024

Study Completion Date

March 22, 2024

Conditions
Coronary Artery Disease
Trial Locations (1)

Unknown

Montreal heart institute, Montreal

Sponsors
All Listed Sponsors
collaborator

Montreal Heart Institute

OTHER

lead

Optina Diagnostics Inc.

INDUSTRY

NCT05199428 - Optina Eye to Heart Connection | Biotech Hunter | Biotech Hunter